re: Ann: Clover 2013FY Results - Investor Pre... Snip from the Tim Boreham from the Australian
"Microequities chief Carlos Gil expects the contamination impact to be "transitory" and confined to the current year. He says that, while pricing pressure is rising, the medical applications are potentially company-changing.
One is a clinical trial to improve the health of premature infants. The results of the 1250-patient effort are due by the end of next year.
Clover is a buy on recent share weakness."
To see the full story you can cut and paste the link into a google search (not the space bar) click on the story and it will come up without needing a subscription.
- See more at: http://www.theaustralian.com.au/business/opinion/milk-contamination-scare-only-transitory/story-e6frg9lo-1226722355624#sthash.T8vuEfrE.dpuf
re: Ann: Clover 2013FY Results - Investor Pre... Snip from the...
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
-0.005(1.01%) |
Mkt cap ! $60.11M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.5¢ | 49.0¢ | $8.983K | 18.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32789 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 44797 | 1 |
View Market Depth
| Last trade - 15.45pm 15/11/2024 (20 minute delay) ? |
| CLV (ASX) Chart |
